ASND
Ascendis A/SFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
ASND vs peer average
15/100
ASND vs. peer average (F vs. C)
Grade spread
A 2 · B 4 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Major biotech with broad commercial muscle and experience integrating acquisitions — relevant for deal/acquirer appetite.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ASND
Ascendis A/S
AMGN
Amgen
Grade
F
D
Momentum
59
93
Value
56
61
Sentiment
0
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs AMGN
ASND / AMGN
Grade Position
Below peers
ASND vs. peer average (F vs. C)
15/100
Momentum
59
AMGNValue
56
AMGNSentiment
0
AMGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ASND
AMGN is the first peer returned for this comparison set.